The FDA issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side ...

This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Common semaglutide side effects include nausea, vomiting, ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or ...

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

EXCLUSIVE: Americans who suffered devastating side effects after taking GLP-1 drugs Ozempic and Wegovy tell Rhian Lubin why they are suing. “If someone would have told me ... a drug I was taking could ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...

ONE GRAND PRIX THIS WEEKEND. FIVE ON YOUR HEALTH TONIGHT. SEVERE SIDE EFFECTS FROM SEMAGLUTIDE, A NATIONAL STUDY FINDS THEY SENT NEARLY 25,000 PEOPLE TO THE ER FOR TREATMENT. JOINING US NOW IS DOCTOR ...

Here's what happens to your heart, liver, skin, and more.

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic ...

The FDA underscored cases including two deaths and a suicide linked to patients taking semaglutide, which Novo markets as Ozempic and Wegovy.